UY36354A - Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y tratamiento de la diabetes - Google Patents

Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y tratamiento de la diabetes

Info

Publication number
UY36354A
UY36354A UY0001036354A UY36354A UY36354A UY 36354 A UY36354 A UY 36354A UY 0001036354 A UY0001036354 A UY 0001036354A UY 36354 A UY36354 A UY 36354A UY 36354 A UY36354 A UY 36354A
Authority
UY
Uruguay
Prior art keywords
diabetes
prevention
treatment
pharmaceutical compositions
insulin
Prior art date
Application number
UY0001036354A
Other languages
English (en)
Inventor
Gagnon Lyne
Grouix Brigitte
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of UY36354A publication Critical patent/UY36354A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32—Phenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al uso de compuestos para prevenir y/o tratar diabetes, para modular los niveles de glucosa, insulina y/o triglicéridos; para reducir el nivel de glucosa en sangre; para mantener o aumentar el nivel de insulina; para aumentar la secreción; aumentar la sensibilidad a la insulina; o disminuir la resistencia a la insulina en un sujeto. Estos usos novedosos se han descubierto para los compuestos representados por la fórmula I descritos en la presente solicitud y las sales farmacéuticamente aceptables de estos.
UY0001036354A 2014-10-10 2015-10-13 Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y tratamiento de la diabetes UY36354A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462062526P 2014-10-10 2014-10-10

Publications (1)

Publication Number Publication Date
UY36354A true UY36354A (es) 2016-06-01

Family

ID=55652427

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036354A UY36354A (es) 2014-10-10 2015-10-13 Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y tratamiento de la diabetes

Country Status (21)

Country Link
US (1) US10105331B2 (es)
EP (1) EP3203998B1 (es)
JP (1) JP6676629B2 (es)
KR (1) KR20170066614A (es)
CN (1) CN106999458B (es)
AR (1) AR102248A1 (es)
AU (1) AU2015330643B2 (es)
BR (1) BR112017007420A2 (es)
CA (1) CA2963276A1 (es)
DK (1) DK3203998T3 (es)
ES (1) ES2875336T3 (es)
IL (1) IL251392B (es)
MX (1) MX2017004738A (es)
PH (1) PH12017500662A1 (es)
PL (1) PL3203998T3 (es)
PT (1) PT3203998T (es)
RU (1) RU2723486C2 (es)
SG (1) SG11201702812PA (es)
TW (1) TWI699201B (es)
UY (1) UY36354A (es)
WO (1) WO2016054726A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017007420A2 (pt) * 2014-10-10 2018-01-16 Prometic Pharma Smt Limited compostos aromáticos substituídos e composições farmacêuticas para impedir e tratar diabetes
RU2728782C2 (ru) 2014-11-12 2020-07-31 Лиминал Байосайенсиз Лимитед Замещенные ароматические соединения и фармацевтические композиции для ауторепарации и регенерации ткани

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
PL377712A1 (pl) * 2003-02-13 2006-02-06 Wellstat Therapeutics Corporation Związki do leczenia zaburzeń metabolicznych
AU2005284798B2 (en) 2004-09-15 2012-02-02 The President And Fellows Of Harvard College Reducing ER stress in the treatment of obesity and diabetes
AT509045B1 (de) * 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H Verbindungen zur behandlung von asthma bronchiale
JP2012072136A (ja) * 2010-09-03 2012-04-12 Erina Co Inc 細胞内代謝促進用組成物、その組成物を含有する糖代謝又は脂質代謝疾患の予防及び／又は治療用医薬製剤、機能性食品及び健康食品
AU2011356584B2 (en) * 2010-10-27 2016-03-10 Liminal Biosciences Limited Compounds and pharmaceutical compositions for uses in diabetes
TWI689490B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
BR112017007420A2 (pt) * 2014-10-10 2018-01-16 Prometic Pharma Smt Limited compostos aromáticos substituídos e composições farmacêuticas para impedir e tratar diabetes

Also Published As

Publication number Publication date
RU2017116106A (ru) 2018-11-12
IL251392B (en) 2020-11-30
AU2015330643B2 (en) 2020-05-14
JP2017530182A (ja) 2017-10-12
EP3203998B1 (en) 2021-03-10
MX2017004738A (es) 2017-08-10
EP3203998A1 (en) 2017-08-16
AR102248A1 (es) 2017-02-15
KR20170066614A (ko) 2017-06-14
AU2015330643A1 (en) 2017-05-04
ES2875336T3 (es) 2021-11-10
BR112017007420A2 (pt) 2018-01-16
TWI699201B (zh) 2020-07-21
CN106999458B (zh) 2021-04-13
US10105331B2 (en) 2018-10-23
WO2016054726A1 (en) 2016-04-14
JP6676629B2 (ja) 2020-04-08
CN106999458A (zh) 2017-08-01
IL251392A0 (en) 2017-05-29
CA2963276A1 (en) 2016-04-14
PT3203998T (pt) 2021-06-07
EP3203998A4 (en) 2018-06-20
PL3203998T3 (pl) 2021-09-27
PH12017500662A1 (en) 2017-10-02
DK3203998T3 (da) 2021-05-31
US20170209399A1 (en) 2017-07-27
SG11201702812PA (en) 2017-05-30
RU2017116106A3 (es) 2019-02-13
TW201618763A (zh) 2016-06-01
RU2723486C2 (ru) 2020-06-11

Similar Documents

Publication Publication Date Title
UY37845A (es) Sulfonilureas y sulfoniltioureas útiles como inhibidores de nlrp3
ECSP13013024A (es) 1,3-oxazinas como inhibidores de bace1 y/o bace2
ECSP13013068A (es) Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2
BR112018005497A2 (pt) compostos heterocíclicos e usos dos mesmos
UY37363A (es) Sulfonilureas y compuestos relacionados y sus usos
DOP2016000271A (es) Compuestos de heteroarilo o arilo bicíclicos fusionados
ECSP13013048A (es) Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores
CR20130432A (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
NI201600018A (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b.
AR099569A1 (es) Derivados de insulina y los usos médicos de estos
DOP2015000241A (es) Compuestos de biaril-amida como inhibidores de cinasa
EA201491335A1 (ru) Бигуанидные композиции и способы лечения метаболических расстройств
DOP2016000226A (es) Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
BR112016015838A8 (pt) compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação
CL2015002608A1 (es) Compuesto de amino-pirazol y usos medicinales relacionados.
EA201391029A1 (ru) Производные оксазина и их применение при лечении неврологических нарушений
UY35142A (es) Derivados de triazolopirazinas como inhibidores de brd4
CL2012003211A1 (es) Compuestos derivados de lactamas sustituidas con piperidinilo, moduladores de gpr119; proceso para preparar los compuestos; composicion farmaceutica que comprende a los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento o prevencion de diabetes tipo 2, obesidad y condiciones relacionadas
DOP2016000212A (es) Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados
UY36875A (es) Composiciones inhibidoras de bromodominios para el tratamiento de diversas enfermedades
CO2017002268A2 (es) Inhibidores espirocíclicos de catepsina c
CO6771450A2 (es) Ureas asimétricas y usos médicos de las mismas
DOP2015000170A (es) Compuestos químicos
CL2021001388A1 (es) Compuestos útiles en la terapia para el vih
UY36145A (es) Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20230414